| - GRCh37:
- Chr2:220283185
- GRCh38:
- Chr2:219418463
| DES | M1V | Desmin-related myofibrillar myopathy, not provided | Likely pathogenic (Mar 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283186
- GRCh38:
- Chr2:219418464
| DES | M1T | Desmin-related myofibrillar myopathy | Likely pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283191
- GRCh38:
- Chr2:219418469
| DES | Q3* | Desmin-related myofibrillar myopathy | Pathogenic (Jan 26, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283219
- GRCh38:
- Chr2:219418497
| DES | S12F | not provided, Primary dilated cardiomyopathy, Neuromuscular disease, Desmin-related myofibrillar myopathy | Pathogenic/Likely pathogenic (May 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283222
- GRCh38:
- Chr2:219418500
| DES | S13F | Desmin-related myofibrillar myopathy, not provided, Primary dilated cardiomyopathy
| Pathogenic (Mar 16, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283230
- GRCh38:
- Chr2:219418508
| DES | R16C | Myofibrillar myopathy | Pathogenic (Aug 16, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:220283294
- GRCh38:
- Chr2:219418572
| DES | A38fs | Desmin-related myofibrillar myopathy | Pathogenic (Jul 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283314
- GRCh38:
- Chr2:219418592
| DES | G44S | not provided | Likely pathogenic (May 2, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283321
- GRCh38:
- Chr2:219418599
| DES | S46Y | not provided | Likely pathogenic (Oct 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283373-220283374
- GRCh38:
- Chr2:219418651-219418652
| DES | L66fs | Desmin-related myofibrillar myopathy | Pathogenic (Feb 3, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283410
- GRCh38:
- Chr2:219418688
| DES | T76fs | Desmin-related myofibrillar myopathy, Dilated cardiomyopathy 1I, Neurogenic scapuloperoneal syndrome, Kaeser type, Desmin-related myofibrillar myopathy | Pathogenic (Oct 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283438-220283439
- GRCh38:
- Chr2:219418716-219418717
| DES | G86fs | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Dec 31, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283483-220283484
- GRCh38:
- Chr2:219418761-219418762
| DES | F101fs | Desmin-related myofibrillar myopathy | Pathogenic (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283492
- GRCh38:
- Chr2:219418770
| DES | T104fs | Desmin-related myofibrillar myopathy | Pathogenic (Jan 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283506
- GRCh38:
- Chr2:219418784
| DES | E108* | Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy, Dilated cardiomyopathy 1I, Neurogenic scapuloperoneal syndrome, Kaeser type, not provided | Pathogenic (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283514-220283522
- GRCh38:
- Chr2:219418792-219418800
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Oct 11, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:220283527
- GRCh38:
- Chr2:219418805
| DES | L115I | Desmin-related myofibrillar myopathy | Pathogenic (Aug 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283530-220283534
- GRCh38:
- Chr2:219418808-219418812
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283531
- GRCh38:
- Chr2:219418809
| DES | N116S | Desmin-related myofibrillar myopathy | Pathogenic/Likely pathogenic (Sep 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283548
- GRCh38:
- Chr2:219418826
| DES | Y122D | not provided | Likely pathogenic (May 8, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283557
- GRCh38:
- Chr2:219418835
| DES | K125* | not provided, Desmin-related myofibrillar myopathy | Pathogenic (Feb 24, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220283560
- GRCh38:
- Chr2:219418838
| DES | V126M | Primary dilated cardiomyopathy | Likely pathogenic (Apr 2, 2020) | no assertion criteria provided |
| - GRCh37:
- Chr2:220283578
- GRCh38:
- Chr2:219418856
| DES | Q132* | Desmin-related myofibrillar myopathy | Pathogenic (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283591
- GRCh38:
- Chr2:219418869
| DES | L136P | not provided, Dilated cardiomyopathy 1S | Likely pathogenic (May 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:220283632-220283639
- GRCh38:
- Chr2:219418910-219418917
| DES | V151fs | Desmin-related myofibrillar myopathy | Pathogenic (Mar 6, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283677-220283704
- GRCh38:
- Chr2:219418955-219418982
| DES | | Dilated cardiomyopathy 1S | Pathogenic (May 1, 2016) | no assertion criteria provided |
| - GRCh37:
- Chr2:220283698
- GRCh38:
- Chr2:219418976
| DES | Q172* | Desmin-related myofibrillar myopathy | Pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283699-220283700
- GRCh38:
- Chr2:219418977-219418978
| DES | V176fs | Desmin-related myofibrillar myopathy | Pathogenic (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283699-220283719
- GRCh38:
- Chr2:219418977-219418997
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Jun 1, 2009) | no assertion criteria provided |
| - GRCh37:
- Chr2:220283700-220283701
- GRCh38:
- Chr2:219418978-219418979
| DES | V176fs | Desmin-related myofibrillar myopathy | Pathogenic (Jun 11, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220284837
- GRCh38:
- Chr2:219420115
| DES | L200* | Desmin-related myofibrillar myopathy | Pathogenic (Jul 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220284838
- GRCh38:
- Chr2:219420116
| DES | K201fs | Neuromuscular disease, Primary dilated cardiomyopathy, Desmin-related myofibrillar myopathy
| Pathogenic/Likely pathogenic (May 27, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220284841
- GRCh38:
- Chr2:219420119
| DES | E202fs | not provided | Likely pathogenic (Jan 3, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220284872
- GRCh38:
- Chr2:219420150
| DES | R212* | Desmin-related myofibrillar myopathy, Neurogenic scapuloperoneal syndrome, Kaeser type, Dilated cardiomyopathy 1I, Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Sep 19, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220284880-220284881
- GRCh38:
- Chr2:219420158-219420159
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Nov 19, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr2:220284972
- GRCh38:
- Chr2:219420250
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Nov 1, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr2:220285033
- GRCh38:
- Chr2:219420311
| DES | E233*, E234* | Desmin-related myofibrillar myopathy | Pathogenic (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285051-220285053
- GRCh38:
- Chr2:219420329-219420331
| DES | K240del, K241del | Desmin-related myofibrillar myopathy | Pathogenic (Mar 15, 2003) | no assertion criteria provided |
| - GRCh37:
- Chr2:220285064-220285070
- GRCh38:
- Chr2:219420342-219420348
| DES | | Desmin-related myofibrillar myopathy | Likely pathogenic (Mar 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285068
- GRCh38:
- Chr2:219420346
| DES | E245D | not provided, Desmin-related myofibrillar myopathy, Dilated cardiomyopathy 1I
| Pathogenic/Likely pathogenic (Mar 14, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220285069
- GRCh38:
- Chr2:219420347
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285069
- GRCh38:
- Chr2:219420347
| DES | | Desmin-related myofibrillar myopathy | Likely pathogenic (Mar 5, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285069
- GRCh38:
- Chr2:219420347
| DES | | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (May 20, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220285070
- GRCh38:
- Chr2:219420348
| DES | | not provided | Likely pathogenic (Dec 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285070
- GRCh38:
- Chr2:219420348
| DES | | Desmin-related myofibrillar myopathy | Likely pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285071
- GRCh38:
- Chr2:219420349
| DES | | Primary dilated cardiomyopathy, Desmin-related myofibrillar myopathy, not provided, Desmin-related myofibrillar myopathy, Cardiovascular phenotype | Pathogenic (Feb 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220285295-220285296
- GRCh38:
- Chr2:219420573-219420574
| DES | A183fs, A272fs, A273fs | not provided | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr2:220285366
- GRCh38:
- Chr2:219420644
| DES | W294*, W295*, W205* | not provided, Desmin-related myofibrillar myopathy, Neurogenic scapuloperoneal syndrome, Kaeser type, Desmin-related myofibrillar myopathy, Dilated cardiomyopathy 1I | Pathogenic/Likely pathogenic (Sep 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220285596-220285600
- GRCh38:
- Chr2:219420874-219420878
| DES | K228fs, K317fs, K318fs | Cardiomyopathy | Likely pathogenic (Jun 9, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285625
- GRCh38:
- Chr2:219420903
| DES | R325* | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Oct 12, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220285661
- GRCh38:
- Chr2:219420939
| DES | A337P | Dilated cardiomyopathy 1I | Pathogenic (Nov 18, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285665
- GRCh38:
- Chr2:219420943
| DES | L338P | Desmin-related myofibrillar myopathy | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220285665
- GRCh38:
- Chr2:219420943
| DES | L338R | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Jan 29, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286062
- GRCh38:
- Chr2:219421340
| DES | N342D | Desmin-related myofibrillar myopathy | Pathogenic (Jul 14, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286063-220286064
- GRCh38:
- Chr2:219421341-219421342
| DES | | Desmin-related myofibrillar myopathy | Likely pathogenic (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286072
- GRCh38:
- Chr2:219421350
| DES | L345P | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286081
- GRCh38:
- Chr2:219421359
| DES | Q348P | Desmin-related myofibrillar myopathy | Pathogenic (Feb 11, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr2:220286087
- GRCh38:
- Chr2:219421365
| DES | R350P | Desmin-related myofibrillar myopathy, not provided | Pathogenic (Apr 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286093
- GRCh38:
- Chr2:219421371
| DES | L262S, L345S, L352S, L351S | Desmin-related myofibrillar myopathy | Likely pathogenic (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286107-220286115
- GRCh38:
- Chr2:219421385-219421393
| DES | | not provided | Pathogenic (Apr 21, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286107
- GRCh38:
- Chr2:219421385
| DES | A357P | not provided | Pathogenic (Jul 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286116
- GRCh38:
- Chr2:219421394
| DES | A360P | Desmin-related myofibrillar myopathy | Pathogenic (Aug 1, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr2:220286127-220286144
- GRCh38:
- Chr2:219421405-219421422
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286128
- GRCh38:
- Chr2:219421406
| DES | Q363*, Q357*, Q364*, Q274* | Desmin-related myofibrillar myopathy | Pathogenic (Oct 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286147
- GRCh38:
- Chr2:219421425
| DES | L370P | Desmin-related myofibrillar myopathy, not provided | Pathogenic (Dec 14, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286168
- GRCh38:
- Chr2:219421446
| DES | L287P, L376P, L354P, L370P, L377P | Desmin-related myofibrillar myopathy | Likely pathogenic (Jun 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286168-220286189
- GRCh38:
- Chr2:219421446-219421467
| DES | K378fs | Desmin-related myofibrillar myopathy | Pathogenic (Jul 10, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286189
- GRCh38:
- Chr2:219421467
| DES | H384R | Desmin-related myofibrillar myopathy | Likely pathogenic (Dec 3, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286192
- GRCh38:
- Chr2:219421470
| DES | L385P | Desmin-related myofibrillar myopathy | Pathogenic (Oct 10, 2000) | no assertion criteria provided |
| - GRCh37:
- Chr2:220286196-220286198
- GRCh38:
- Chr2:219421474-219421476
| DES | | Progressive familial heart block, Bradycardia | Likely pathogenic (Dec 23, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286204
- GRCh38:
- Chr2:219421482
| DES | Q389P | Desmin-related myofibrillar myopathy | Pathogenic (Nov 1, 2001) | no assertion criteria provided |
| - GRCh37:
- Chr2:220286208
- GRCh38:
- Chr2:219421486
| DES | L247fs, L301fs, L384fs, L390fs, L391fs, L368fs | Desmin-related myofibrillar myopathy | Pathogenic (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286216
- GRCh38:
- Chr2:219421494
| DES | N393I | Desmin-related myofibrillar myopathy | Pathogenic (Aug 1, 1998) | no assertion criteria provided |
| - GRCh37:
- Chr2:220286233
- GRCh38:
- Chr2:219421511
| DES | D399Y | Desmin-related myofibrillar myopathy | Likely pathogenic (Mar 16, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286239
- GRCh38:
- Chr2:219421517
| DES | E401K | Desmin-related myofibrillar myopathy | Likely pathogenic (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286240
- GRCh38:
- Chr2:219421518
| DES | E394G, E311G, E378G, E400G, E401G, E257G | Desmin-related myofibrillar myopathy | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286251
- GRCh38:
- Chr2:219421529
| DES | Y405fs | not provided, Desmin-related myofibrillar myopathy | Pathogenic (Feb 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286252
- GRCh38:
- Chr2:219421530
| DES | Y382S, Y405S, Y315S, Y398S, Y261S, Y404S | Desmin-related myofibrillar myopathy | Likely pathogenic (Sep 15, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286254
- GRCh38:
- Chr2:219421532
| DES | R406W | Desmin-related myofibrillar myopathy, not provided, Arrhythmogenic right ventricular cardiomyopathy, Cardiomyopathy | Pathogenic/Likely pathogenic (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286255
- GRCh38:
- Chr2:219421533
| DES | R405P, R316P, R262P, R406P, R383P, R399P | Desmin-related myofibrillar myopathy | Likely pathogenic (Oct 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286261
- GRCh38:
- Chr2:219421539
| DES | L408fs | not provided | Likely pathogenic (Dec 23, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286275
- GRCh38:
- Chr2:219421553
| DES | E413* | Desmin-related myofibrillar myopathy | Pathogenic (Feb 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220286275
- GRCh38:
- Chr2:219421553
| DES | E413K | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Dec 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220286283
- GRCh38:
- Chr2:219421561
| DES | | Desmin-related myofibrillar myopathy | Likely pathogenic (Jul 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220288506-220288522
- GRCh38:
- Chr2:219423784-219423800
| DES | P419fs | Desmin-related myofibrillar myopathy, not provided | Pathogenic (Jun 1, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220288509
- GRCh38:
- Chr2:219423787
| DES | P419S | Desmin-related myofibrillar myopathy, not provided | Pathogenic/Likely pathogenic (Aug 24, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220288539
- GRCh38:
- Chr2:219423817
| DES | R429* | Primary familial dilated cardiomyopathy, Desmin-related myofibrillar myopathy, Primary dilated cardiomyopathy, Neuromuscular disease, not provided, Desmin-related myofibrillar myopathy
| Pathogenic/Likely pathogenic (Nov 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220289644
- GRCh38:
- Chr2:219424922
| DES | | not provided | Pathogenic (Feb 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220290383
- GRCh38:
- Chr2:219425661
| DES | | Desmin-related myofibrillar myopathy, Abnormality of the musculature, not provided
| Pathogenic/Likely pathogenic (Mar 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220290421
- GRCh38:
- Chr2:219425699
| DES | T442I | Desmin-related myofibrillar myopathy, not provided | Pathogenic (Aug 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220290442
- GRCh38:
- Chr2:219425720
| DES | K449T | not provided, Desmin-related myofibrillar myopathy | Pathogenic/Likely pathogenic (Dec 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr2:220290468
- GRCh38:
- Chr2:219425746
| DES | | not provided | Likely pathogenic (Apr 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220290711
- GRCh38:
- Chr2:219425989
| DES | | not provided | Likely pathogenic (Jun 11, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283185-220290712
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220284797-220284897
| DES | | Desmin-related myofibrillar myopathy | Likely pathogenic (Jan 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr2:220283175-220290722
| DES | | Desmin-related myofibrillar myopathy | Pathogenic (Feb 6, 2019) | criteria provided, single submitter |